Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?
Oruka Therapeutics Ownership Summary
Oruka Therapeutics is owned by 81.50% institutional investors, 3.82% insiders, and 14.68% retail investors. Vr adviser is the largest institutional shareholder, holding 9.82% of ORKA shares.
ORKA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Oruka Therapeutics | 81.50% | 3.82% | 14.68% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vr adviser | 4.15M | 9.82% | $46.50M |
| Fairmount funds management | 3.37M | 7.98% | $37.80M |
| Blackrock funding, inc. /de | 1.99M | 4.71% | $22.30M |
| Rtw investments, lp | 1.95M | 4.61% | $21.81M |
| Deep track capital, lp | 1.92M | 4.54% | $21.51M |
| Braidwell lp | 1.52M | 3.61% | $17.09M |
| Polar capital | 975.00K | 2.31% | $10.93M |
| Mercer global advisors inc /adv | 852.34K | 2.02% | $9.55M |
| Blackstone | 826.72K | 1.96% | $9.27M |
| Affinity asset advisors | 603.48K | 1.43% | $6.76M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fairmount funds management | 3.37M | 4.90% | $37.80M |
| Vr adviser | 4.15M | 3.48% | $46.50M |
| Affinity asset advisors | 603.48K | 0.92% | $6.76M |
| Avidity partners management lp | 352.12K | 0.79% | $3.95M |
| Deep track capital, lp | 1.92M | 0.69% | $21.51M |
| Braidwell lp | 1.52M | 0.58% | $17.09M |
| Silverarc capital management | 165.39K | 0.34% | $1.85M |
| Rtw investments, lp | 1.95M | 0.31% | $21.81M |
| Frazier life sciences management | 583.33K | 0.26% | $6.54M |
| Adar1 capital management | 142.78K | 0.25% | $1.60M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 1.99M | 0.00% | 1.24M |
| Mercer global advisors inc /adv | 852.34K | 0.02% | 852.34K |
| Deep track capital, lp | 1.92M | 0.69% | 474.09K |
| Silverarc capital management | 165.39K | 0.34% | 165.39K |
| Abrdn | 78.38K | 0.00% | 78.38K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | - | - | -849.41K |
| Perceptive advisors | - | - | -845.57K |
| Paradigm biocapital advisors lp | - | - | -819.66K |
| Redmile group | - | - | -386.96K |
| Jefferies financial group | 64.99K | 0.01% | -340.04K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Mercer global advisors inc /adv | 852.34K | 0.02% | 852.34K | $9.55M |
| Silverarc capital management | 165.39K | 0.34% | 165.39K | $1.85M |
| Abrdn | 78.38K | 0.00% | 78.38K | $878.64K |
| Intech investment management | 15.03K | 0.00% | 15.03K | $168.43K |
| Sterling capital management | 734.00 | 0.00% | 734.00 | $8.23K |
Sold Out
| Holder | Change |
|---|---|
| Coldstream capital management | -180.00 |
| Group one trading | -2.11K |
| Artia global partners lp | -7.38K |
| Jane street group | -17.71K |
| Cannon global investment management | -19.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 80 | 17.65% | 34,421,525 | 22.70% | 81 | 1.80% | 53 | 20.45% | 14 | 27.27% |
| Mar 31, 2025 | 70 | 7.69% | 31,776,535 | 2.46% | 76 | 1.28% | 44 | -8.33% | 11 | 37.50% |
| Dec 31, 2024 | 66 | 57.14% | 31,038,321 | 26.38% | 77 | 0.29% | 49 | 16.67% | 8 | - |
| Sep 30, 2024 | 42 | - | 24,559,501 | - | 163 | - | 42 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $1.02M |
| Feb 13, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $173.87K |
| Feb 12, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $106.40K |
| Feb 11, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $105.04K |
| Feb 10, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $6.26K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 5 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
ORKA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools